Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Kessler

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Vaccines|March 19, 2013
Therapeutic vaccines against tobacco addictionRaafat E F Fahim, Paul D Kessler, Matthew W Kalnik
CNS & Neurological Disorders Drug Targets|January 11, 2012
Nicotine vaccinesRaafat E F Fahim, Paul D Kessler, Steven A Fuller, et al.
Circulation|January 5, 2002
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heartCatalin Toma, Mark F Pittenger, Kevin S Cahill, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2003
Cell therapy in the heart: cell production, transplantation, and applicationsKevin S Cahill, Catalin Toma, Mark F Pittenger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2008
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) studyWajeh Qunibi, Moustafa Moustafa, Larry R Muenz, et al.
Journal of the American College of Cardiology|February 19, 2021
Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseaseShmuel Fuchs, Nabil Dib, Barry M Cohen, et al.
JACC. Heart Failure|August 18, 2020
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented modelKai Wang, Paul D Kessler, Zhongmin Zhou, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Vaccines|March 19, 2013
Therapeutic vaccines against tobacco addictionRaafat E F Fahim, Paul D Kessler, Matthew W Kalnik
CNS & Neurological Disorders Drug Targets|January 11, 2012
Nicotine vaccinesRaafat E F Fahim, Paul D Kessler, Steven A Fuller, et al.
Circulation|January 5, 2002
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heartCatalin Toma, Mark F Pittenger, Kevin S Cahill, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2003
Cell therapy in the heart: cell production, transplantation, and applicationsKevin S Cahill, Catalin Toma, Mark F Pittenger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2008
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) studyWajeh Qunibi, Moustafa Moustafa, Larry R Muenz, et al.
Journal of the American College of Cardiology|February 19, 2021
Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseaseShmuel Fuchs, Nabil Dib, Barry M Cohen, et al.
JACC. Heart Failure|August 18, 2020
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented modelKai Wang, Paul D Kessler, Zhongmin Zhou, et al.
Pageof 2